Publication | Open Access

Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Breast OncologyNeoadjuvant ChemotherapyMedicineBreast CancerCancer TreatmentResidual Cancer BurdenOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences